Biotechnology News

April 29, 2012

--(BUSINESS WIRE)--The National Bioeconomy Blueprint, released by the White House, will be discussed by industry executives and agency leaders at BIO's World Congress on Industrial Biotechnology held in Orlando.

April 29, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US and Non-UK Healthcare Media Only New data show that TWYNSTA®, a once daily, single pill combination of the angiotensin II receptor blocker (ARB) telmisartan and the calcium channel blocker (CCB)...

April 27, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in two jointly related patent...

April 27, 2012

WASHINGTON--(BUSINESS WIRE)--Reps. Bill Pascrell (D-NJ) and Brian Bilbray (R-CA) introduced legislation granting renewable chemical companies a production tax credit

April 27, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today that it will be participating in the Goldman Sachs Leveraged Finance Healthcare Conference in New York, New York on May 1, 2012 at 2:00 p.m. Eastern Time. A link to the presentation will...

April 27, 2012

--(BUSINESS WIRE)--The community is invited to attend the 9th Annual Celebration of Biotechnology on Thursday, May 10 from 9:30 a.m. until 1 p.m. on the RTI Biologics campus in Progress Corporate Park, Alachua, Fla.

April 27, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo announced that it has been notified by the ICC that the anticipated date of the arbitration decision in its demand for arbitration has been extended from April 30 to May 31.

April 27, 2012

--(BUSINESS WIRE)--The National Bioeconomy Blueprint, released by the White House, will be discussed by industry executives and agency leaders at BIO's World Congress on Industrial Biotechnology held in Orlando.

April 27, 2012

MADISON, Wis.--(BUSINESS WIRE)--Stratatech Corp. announced positive preliminary results from the ongoing clinical trial of its StrataGraft human skin substitute.

April 27, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that the Tech Council of Maryland (TCM) has...

April 27, 2012

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Medtronic, Inc., (NYSE: MDT), announced today six month pooled outcomes from randomized and crossover patients in the Symplicity HTN-2 clinical trial following renal denervation with the Symplicity™...

April 27, 2012

MADRID & SINGAPORE--(BUSINESS WIRE)--FAES FARMA, a leading Spanish pharmaceutical group dedicated to research, development, manufacturing and marketing of pharmaceuticals, and INVIDA Holdings Private Limited, a Member of the MENARINI Group...

April 27, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics schedules first quarter 2012 financial results and conference call for May 8, 2012.

April 27, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) invites investors and the general public to listen to a webcast of its annual meeting of stockholders at 10 a.m. (ET) on Tuesday, May 1, 2012. In addition to the items being...

April 27, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter presented Phase III clinical data evaluating the safety and efficacy of GAMMAGARD LIQUID for the treatment of MMN during the American Academy of Neurology Annual Meeting in New Orleans.

April 27, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that its Annual Meeting of Stockholders will be webcast live beginning May 1, 2012 at 9:00 a.m. Eastern Daylight Time via the...

April 27, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its first quarter 2012 financial results on Thursday, May 3, 2012 at approximately 4:30 p.m. ET. The press release will be followed by...

April 27, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced today the release of Version 8.0 of...

April 27, 2012

NEWARK, Del.--(BUSINESS WIRE)--Delaware Bio hosted its 2012 Annual Awards Gala, where over 300 academic, government, and industry leaders gathered to celebrate Incyte and 3 individuals who made significant contributions in Delaware

April 27, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks has been ranked #2 Powerhouse Company as part of the 2012 Pacesetters program by the Boston Business Journal.

April 27, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex (STO:ALNX) sells its holding in Pharmacolog i Uppsala AB to some of the other owners in the company for sek 300.000 Pharmacolog is a company that develop systems to control content and...

April 27, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE Amex: NAVB) First Quarter 2012 Earnings and Business Update Conference Call Invitation: Conference Call Scheduled for 8:30 AM EDT, Thursday, May 3rd

April 27, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today reported financial results for...

April 27, 2012

LUND, Sweden & MUNICH--(BUSINESS WIRE)--Night dialysis treatment improves both health and quality of life – new shifts across Europe Diaverum, one of the world’s leading renal care service providers, is further expanding its service portfolio...

April 27, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: At the Annual General Meeting held in Biotage AB (Reg. No. 556539-3138)(STO:BIOTA) on April 26, 2012, the following resolutions were passed, among others. Appropriation of the company’s result...

April 27, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: As a part of Allenex (STO:ALNX) focus to build a global transplantation technology company with a strong sales and support organization the company now choose to sell directly to end customers in...

April 27, 2012

DUBLIN--(BUSINESS WIRE)--Elan to Present at Deutsche Bank Health Care Conference

April 27, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that Fuad El-Hibri, its executive chairman of the board, has been recognized as Executive of the Year by the Tech Council of Maryland (TCM), the state’s...

April 26, 2012

TRENTON, N.J.--(BUSINESS WIRE)--BioNJ’s May 10-11 International BioPartnering Conference to feature Dr. Marc Bonnefoi of Sanofi, Peter Kellogg of Merck & Co., Inc., and Dr. Walter Moos of SRI International.

April 26, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the first quarter ended April 1, 2012. The Company...

April 26, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended March 31, 2012. Total revenues for the first quarter of 2012 increased 19 percent to $2.28 billion, from $1...

April 26, 2012

CLARENCE, N.Y.--(BUSINESS WIRE)--Greatbatch, Inc. (NYSE: GB) today announced results for its first quarter ended March 30, 2012: Sales increased 7% to a record $159.1 million, driven by the Micro Power acquisition. On an organic constant currency...

April 26, 2012

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced its results for the first quarter ended March 31, 2012. Net sales of $143.1 million represent an increase of 3% over the first quarter...

April 26, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced that Ron Squarer has been appointed Chief Executive Officer, effective immediately. Mr. Squarer has also been named to the Array Board of Directors. Mr. Squarer...

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Reports First Quarter 2012 Financial Results and Provides Update on Launch of KALYDECOTM

April 26, 2012

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its first quarter ended March...

April 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the first quarter ending March 31, 2012 on Thursday, May 3, 2012,...

April 26, 2012

WASHINGTON--(BUSINESS WIRE)--BIO submitted testimony to the House Ways and Means subcommittee on the importance of tax extenders for advanced biofuels

April 26, 2012

ATLANTA--(BUSINESS WIRE)--Dodge Communications, an integrated communications agency, has joined the Metro Atlanta Chamber (MAC) Board of Advisors and the BioScience and Health IT Leadership Council.

April 26, 2012

MISGAV, Israel and SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue,...

April 26, 2012

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced findings from several studies of TYSABRI® (natalizumab) evaluating its long-term safety and efficacy in the treatment of...

April 26, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--The Coalition to Cure Prostate Cancer (CCPC) is a new Canadian Foundation — formed in the last year — committed to accelerating advanced research with the ultimate goal of ending death and suffering...

April 26, 2012

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced findings from several studies of TYSABRI® (natalizumab) evaluating its long-term safety and efficacy in the treatment of...

April 26, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Entrepreneurs with startups or business plans serving the baby boomer market are invited to apply to the 9th annual Silicon Valley Boomer Venture Summit and Business Plan Competition at SCU June 20.

April 26, 2012

BOULDER, Colo.--(BUSINESS WIRE)--miRagen announces new data suggesting expanded therapeutic potential for lead program in both metabolic disorders and cardiovascular disease. Findings published today in the journal Cell.

April 26, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Patient adherence teams for many drug brands are boosting spending this year on new digital tools in a bid to better reach patients and drive higher patient adherence.

April 26, 2012

WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the Obama Administration's new National Bioeconomy Blueprint issued today: “BIO applauds President...